Bladder adenocarcinoma

MONDO:0002751

A carcinoma that arises from glandular epithelial cells of the urinary bladder

Also known as: adenocarcinoma of bladder, adenocarcinoma of the bladder, adenocarcinoma of the urinary bladder, adenocarcinoma of urinary bladder, bladder adenocarcinoma, urinary bladder adenocarcinoma, blad

2779 clinical trials for this condition and its sub-types, 5 tagged with Bladder adenocarcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Adenocarcinoma (5262) ↑ Urinary bladder carcinoma (673)

Sub-types of Bladder adenocarcinoma

Bladder urachal adenocarcinoma 5 trials
Bladder clear cell adenocarcinoma 1 trial
3 sub-types
- Bladder diffuse clear cell adenocarcinoma 0 trials
- Bladder papillary clear cell adenocarcinoma 0 trials
- Bladder tubulo-cystic clear cell adenocarcinoma 0 trials
Bladder mixed adenocarcinoma 1 trial
Bladder colloid adenocarcinoma 0 trials
Bladder colonic type adenocarcinoma 0 trials
Bladder hepatoid adenocarcinoma 0 trials
Bladder signet ring cell adenocarcinoma 0 trials

Including sub-types (2779) Tagged with Bladder adenocarcinoma (5)

Trials to join now! 4 Not yet finished but already full! 1

Immunotherapy duo takes on rare tumors

Disease control Ongoing

This phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

Bladder adenocarcinoma

Where it sits in the disease tree

Immunotherapy duo takes on rare tumors